 
| In ZINC since | Heavy atoms | Benign functionality | 
|---|---|---|
| May 8th, 2008 | 28 | No | 
Popular Name: Cdk1/2InhibitorIII Cdk1/2InhibitorIII
Find On: PubMed — Wikipedia — Google
CAS Number: 443798-55-8
5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL | 
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 2.39 | 7.08 | -16.53 | 6 | 9 | 0 | 141 | 425.446 | 6 | ↓ | 
| Hi High (pH 8-9.5) | 2.43 | 7.94 | -52.61 | 5 | 9 | -1 | 141 | 424.438 | 5 | ↓ | 
| Note Type | Comments | Provided By | 
|---|---|---|
| ALOGPS_SOLUBILITY | 8.75e-03 g/l | DrugBank-experimental | 
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type | 
|---|---|---|---|---|---|
| CCNA1-1-E | Cyclin A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM | 
| CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM | 
| CCNB1-1-E | G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM | 
| CCNB2-1-E | G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM | 
| CCNB3-1-E | G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM | 
| CDK1-3-E | Cyclin-dependent Kinase 1 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM | 
| CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM | 
| E2AK2-1-E | Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM | 
| GSK3A-1-E | Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 140 | 0.34 | Binding ≤ 10μM | 
| GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 140 | 0.34 | Binding ≤ 10μM | 
| KAPCA-1-E | CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #1 Of 4), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM | 
| KAPCB-1-E | CAMP-dependent Protein Kinase Beta-1 Catalytic Subunit (cluster #1 Of 3), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM | 
| KAPCG-1-E | CAMP-dependent Protein Kinase, Gamma Catalytic Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM | 
| KC1A-1-E | Casein Kinase I Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM | 
| KC1D-1-E | Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM | 
| KC1E-1-E | Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM | 
| KC1G1-1-E | Casein Kinase I Gamma 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM | 
| KC1G2-1-E | Casein Kinase I Gamma 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM | 
| KCC2A-1-E | CaM Kinase II Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8900 | 0.25 | Binding ≤ 10μM | 
| KCC2B-1-E | CaM Kinase II Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8900 | 0.25 | Binding ≤ 10μM | 
| KCC2D-1-E | CaM Kinase II Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8900 | 0.25 | Binding ≤ 10μM | 
| KCC2G-1-E | CaM Kinase II Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8900 | 0.25 | Binding ≤ 10μM | 
| PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM | 
| PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM | 
| Q95J97-1-E | CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM | 
| VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 32 | 0.37 | Binding ≤ 10μM | 
| Z104300-1-O | Mitogen-activated Protein Kinase; ERK1/ERK2 (cluster #1 Of 1), Other | Other | 1000 | 0.30 | Binding ≤ 10μM | 
| Z103203-1-O | A375 (cluster #1 Of 3), Other | Other | 92 | 0.35 | Functional ≤ 10μM | 
| Z80018-2-O | A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other | Other | 92 | 0.35 | Functional ≤ 10μM | 
| Z80928-1-O | HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other | Other | 20 | 0.38 | Functional ≤ 10μM | 
| Z81247-1-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other | Other | 35 | 0.37 | Functional ≤ 10μM | 
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type | 
|---|---|---|---|---|---|
| CCNA1_HUMAN | P78396 | Cyclin A1, Human | 0.5 | 0.47 | Binding ≤ 1μM | 
| CCNA2_HUMAN | P20248 | Cyclin A2, Human | 0.5 | 0.47 | Binding ≤ 1μM | 
| CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 0.6 | 0.46 | Binding ≤ 1μM | 
| CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 0.5 | 0.47 | Binding ≤ 1μM | 
| CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 0.6 | 0.46 | Binding ≤ 1μM | 
| CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 0.6 | 0.46 | Binding ≤ 1μM | 
| CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 0.6 | 0.46 | Binding ≤ 1μM | 
| GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 140 | 0.34 | Binding ≤ 1μM | 
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 140 | 0.34 | Binding ≤ 1μM | 
| Z104300 | Z104300 | Mitogen-activated Protein Kinase; ERK1/ERK2 | 1000 | 0.30 | Binding ≤ 1μM | 
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 32 | 0.37 | Binding ≤ 1μM | 
| VGFR2_MOUSE | P35918 | Vascular Endothelial Growth Factor Receptor 2, Mouse | 32 | 0.37 | Binding ≤ 1μM | 
| KCC2A_HUMAN | Q9UQM7 | CaM Kinase II Alpha, Human | 8900 | 0.25 | Binding ≤ 10μM | 
| KCC2B_HUMAN | Q13554 | CaM Kinase II Beta, Human | 8900 | 0.25 | Binding ≤ 10μM | 
| KCC2D_HUMAN | Q13557 | CaM Kinase II Delta, Human | 8900 | 0.25 | Binding ≤ 10μM | 
| KCC2G_HUMAN | Q13555 | CaM Kinase II Gamma, Human | 8900 | 0.25 | Binding ≤ 10μM | 
| KAPCA_HUMAN | P17612 | CAMP-dependent Protein Kinase Alpha-catalytic Subunit, Human | 5200 | 0.26 | Binding ≤ 10μM | 
| Q95J97_RABIT | Q95J97 | CAMP-dependent Protein Kinase Alpha-catalytic Subunit, Rabit | 5200 | 0.26 | Binding ≤ 10μM | 
| KAPCB_HUMAN | P22694 | CAMP-dependent Protein Kinase Beta-1 Catalytic Subunit, Human | 5200 | 0.26 | Binding ≤ 10μM | 
| KAPCG_HUMAN | P22612 | CAMP-dependent Protein Kinase, Gamma Catalytic Subunit, Human | 5200 | 0.26 | Binding ≤ 10μM | 
| KC1A_HUMAN | P48729 | Casein Kinase I Alpha, Human | 2800 | 0.28 | Binding ≤ 10μM | 
| KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 2800 | 0.28 | Binding ≤ 10μM | 
| KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 2800 | 0.28 | Binding ≤ 10μM | 
| KC1G1_HUMAN | Q9HCP0 | Casein Kinase I Gamma 1, Human | 2800 | 0.28 | Binding ≤ 10μM | 
| KC1G2_HUMAN | P78368 | Casein Kinase I Gamma 2, Human | 2800 | 0.28 | Binding ≤ 10μM | 
| CCNA1_HUMAN | P78396 | Cyclin A1, Human | 0.5 | 0.47 | Binding ≤ 10μM | 
| CCNA2_HUMAN | P20248 | Cyclin A2, Human | 0.5 | 0.47 | Binding ≤ 10μM | 
| CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 0.6 | 0.46 | Binding ≤ 10μM | 
| CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 0.5 | 0.47 | Binding ≤ 10μM | 
| CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 0.6 | 0.46 | Binding ≤ 10μM | 
| CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 0.6 | 0.46 | Binding ≤ 10μM | 
| CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 0.6 | 0.46 | Binding ≤ 10μM | 
| GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 140 | 0.34 | Binding ≤ 10μM | 
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 140 | 0.34 | Binding ≤ 10μM | 
| E2AK2_HUMAN | P19525 | Interferon-induced, Double-stranded RNA-activated Protein Kinase, Human | 1600 | 0.29 | Binding ≤ 10μM | 
| Z104300 | Z104300 | Mitogen-activated Protein Kinase; ERK1/ERK2 | 1000 | 0.30 | Binding ≤ 10μM | 
| PGFRA_RAT | P20786 | Platelet-derived Growth Factor Receptor Alpha, Rat | 1600 | 0.29 | Binding ≤ 10μM | 
| PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 1600 | 0.29 | Binding ≤ 10μM | 
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 32 | 0.37 | Binding ≤ 10μM | 
| VGFR2_MOUSE | P35918 | Vascular Endothelial Growth Factor Receptor 2, Mouse | 32 | 0.37 | Binding ≤ 10μM | 
| Z80018 | Z80018 | A-375 (Malignant Melanoma Cells) | 92 | 0.35 | Functional ≤ 10μM | 
| Z103203 | Z103203 | A375 | 92 | 0.35 | Functional ≤ 10μM | 
| Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 20 | 0.38 | Functional ≤ 10μM | 
| Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 35 | 0.37 | Functional ≤ 10μM | 
| Description | Species | 
|---|---|
| Activation of ATR in response to replication stress | |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
| Activation of the pre-replicative complex | |
| AKT phosphorylates targets in the cytosol | |
| APC truncation mutants have impaired AXIN binding | |
| APC/C:Cdc20 mediated degradation of Cyclin B | |
| AXIN missense mutants destabilize the destruction complex | |
| Beta-catenin phosphorylation cascade | |
| Ca2+ pathway | |
| CDK-mediated phosphorylation and removal of Cdc6 | |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
| Circadian Clock | |
| Condensation of Prometaphase Chromosomes | |
| Condensation of Prophase Chromosomes | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| CREB phosphorylation through the activation of Adenylate Cyclase | |
| CREB phosphorylation through the activation of CaMKII | |
| CREB phosphorylation through the activation of Ras | |
| CRMPs in Sema3A signaling | |
| Cyclin A/B1 associated events during G2/M transition | |
| Cyclin A:Cdk2-associated events at S phase entry | |
| Cyclin B2 mediated events | |
| Cyclin E associated events during G1/S transition | |
| DARPP-32 events | |
| Degradation of beta-catenin by the destruction complex | |
| Depolymerisation of the Nuclear Lamina | |
| disassembly of the destruction complex and recruitment of AXIN to the membrane | |
| DNA Damage/Telomere Stress Induced Senescence | |
| Downstream signal transduction | |
| E2F mediated regulation of DNA replication | |
| E2F-enabled inhibition of pre-replication complex formation | |
| EPHA-mediated growth cone collapse | |
| ERK1 activation | |
| Factors involved in megakaryocyte development and platelet production | |
| G0 and Early G1 | |
| G1/S-Specific Transcription | |
| G2 Phase | |
| G2/M DNA replication checkpoint | |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | |
| Gluconeogenesis | |
| Golgi Cisternae Pericentriolar Stack Reorganization | |
| Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |
| HSF1-dependent transactivation | |
| Inhibition of PKR | |
| Integrin cell surface interactions | |
| Interferon gamma signaling | |
| Interleukin-3, 5 and GM-CSF signaling | |
| ISG15 antiviral mechanism | |
| Loss of Nlp from mitotic centrosomes | |
| Loss of proteins required for interphase microtubule organization from the ce | |
| MASTL Facilitates Mitotic Progression | |
| Meiotic recombination | |
| misspliced GSK3beta mutants stabilize beta-catenin | |
| Neurophilin interactions with VEGF and VEGFR | |
| Nuclear Pore Complex (NPC) Disassembly | |
| Orc1 removal from chromatin | |
| p53-Dependent G1 DNA Damage Response | |
| Phosphorylation of Emi1 | |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
| Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
| Phosphorylation of the APC/C | |
| PIP3 activates AKT signaling | |
| PKA activation | |
| PKA activation in glucagon signalling | |
| PKA-mediated phosphorylation of CREB | |
| PKA-mediated phosphorylation of key metabolic factors | |
| Polo-like kinase mediated events | |
| Rap1 signalling | |
| Ras activation uopn Ca2+ infux through NMDA receptor | |
| Recruitment of mitotic centrosome proteins and complexes | |
| Recruitment of NuMA to mitotic centrosomes | |
| Regulation of APC/C activators between G1/S and early anaphase | |
| Regulation of HSF1-mediated heat shock response | |
| Regulation of insulin secretion | |
| Regulation of PLK1 Activity at G2/M Transition | |
| Resolution of Sister Chromatid Cohesion | |
| S33 mutants of beta-catenin aren't phosphorylated | |
| S37 mutants of beta-catenin aren't phosphorylated | |
| S45 mutants of beta-catenin aren't phosphorylated | |
| SCF(Skp2)-mediated degradation of p27/p21 | |
| Senescence-Associated Secretory Phenotype (SASP) | |
| Signaling by PDGF | |
| Sphingolipid de novo biosynthesis | |
| T41 mutants of beta-catenin aren't phosphorylated | |
| Trafficking of AMPA receptors | |
| truncations of AMER1 destabilize the destruction complex | |
| Unblocking of NMDA receptor, glutamate binding and activation | |
| Vasopressin regulates renal water homeostasis via Aquaporins | |
| VEGF binds to VEGFR leading to receptor dimerization | |
| VEGFA-VEGFR2 Pathway | |
| VEGFR2 mediated cell proliferation | |
| WNT mediated activation of DVL | |
| XBP1(S) activates chaperone genes | 
No pre-computed analogs available. Try a structural similarity search.